.Following a bad showing for Lykos Therapies' MDMA prospect for trauma at a current FDA consultatory...
.AN2 Therapies is reconsidering its own service in response to uninspired midphase data, pledging to...
.Merck & Co. is paying $700 million upfront to test Amgen in a blood stream cancer market. The de...
.With Gilead Sciences on the verge of an FDA choice for its liver disease medicine seladelpar, the f...
.CEO David Ricks can easily view the business setting up tents at basecamp behind Eli Lilly in an at...
.Bed mattress Liquidators has actually turned Entero Rehabs white as a slab. The lender purchased En...
.Exelixis is actually quiting on its own cells aspect (TF)- targeting antibody-drug conjugate after ...
.Three weeks after Roche's Genentech device bowed out an SHP2 inhibitor treaty, Relay Therapy has co...
.Stoke Therapeutics' Dravet syndrome medication has been actually devoid of a partial hold, getting ...
.Fierce Biotech Partner Editor Gabrielle Masson showed the 2024 course of Tough 15 champions on the ...